- PLN19.10m
- PLN16.24m
- PLN2.34m
Brief: Genxone 1.2 Mln Zloty Offer For NGS Sequencing Services Chosen As Most Favourable In Tender
Brief: Genxone Signs 93,990 Zloty Contract With Medical University Of Warsaw For Gut Microbiota DNA Sequencing Services
Brief: Genxone Q1 Net Loss 0.5 Million Zlotys
Brief: Genxone FY Net Loss 2.6 Million Zlotys
Brief: Genxone Offer For DNA Sequencing Project Chosen As Most Favourable By Medical University Of Warsaw
Brief: Genxone Signs Deal With National Institute Of Geriatrics For Microbiome Sequencing Services
Brief: Genxone Offer For Microbiome Sequencing Services Chosen As Most Favorable In Tender
Brief: genXone Q4 Net Loss At 0.2 Million Zlotys
Brief: Genxone Q3 Net Loss At 0.6 Mln Zlotys
Brief: Gexone 194.1 Mln Zlotys Offer Chosen As Most Favourable In Tender
Brief: Genxone Q2 Net Loss At 0.6 Mln Zlotys
Brief: Genxone Q1 Net Loss At 0.7 Mln Zlotys
Brief: Genxone FY Net Loss At 3.9 Mln Zlotys
Brief: Genxone Q4 Net Loss At 1.5 Mln Zlotys
Brief: Genxone Q3 Net Loss At 0.8 Mln Zlotys
Brief: Genxone FY Net Result Turns To Loss Of 3.7 Mln Zlotys
Brief: Genxone 4.3 Mln Zloty Offer Chosen As Most Favourable In Tender
Brief: Genxone 3.1 Mln Zloty Offer Chosen As Most Favourable In Tender
Brief: Genxone Q3 Net Loss Widens At 1.3 Mln Zlotys